| (Values in U.S. Thousands) | Dec, 2021 | Sep, 2021 | Jun, 2021 | Mar, 2021 | Dec, 2020 |
| Sales | 100 | 110 | 30 | 70 | 70 |
| Sales Growth | -9.09% | +266.67% | -57.14% | unch | -12.50% |
| Net Income | -1,540 | -1,740 | -830 | -2,020 | -20 |
| Net Income Growth | +11.49% | -109.64% | +58.91% | -10,000.50% | +96.88% |
Tauriga Sciences Inc (TAUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Tauriga Sciences, Inc. is a diversified life sciences company focused on the development of a proprietary technology platform in the synthetic biology space. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Tauriga Sciences, Inc. is headquartered in Danbury, Connecticut.
Fiscal Year End Date: 03/31